Vitamin D deficiency and the COVID-19 pandemic
Patrick Zemb(Centre Hospitalier de Bretagne Sud), Peter Bergman(Karolinska Institutet), Carlos A. Camargo(Harvard University), Étienne Cavalier(Centre Hospitalier Universitaire de Liège), Catherine Cormier(Hôpital Cochin), Marie Courbebaisse(Hôpital Européen), Bruce W. Hollis(Medical University of South Carolina), Fabrice Joulia(Inserm), Salvatore Minisola(Policlinico Umberto I), Stefan Pilz(University of Graz), Paweł Płudowski(Children's Memorial Health Institute), François Schmitt(Centre Hospitalier de Bretagne Sud), Mihnea Zdrenghea(Iuliu Hațieganu University of Medicine and Pharmacy), Jean-Claude Souberbielle(Hôpital Necker-Enfants Malades)
Cited by 107Open Access
Abstract
• Vitamin D deficiency is very common. • Randomised controlled trials showed that vitamin D decreases acute respiratory infections (ARIs). • Vitamin D deficiency is an easily modifiable factor of ARIs. • Daily vitamin D supplementation with moderate doses is safe and cheap. • Even a small decrease in COVID-19 infections would easily justify this intervention.
Related Papers
No related papers found
Powered by citation graph analysis